Table 1.
Incidence of common adverse effects (%) in patients receiving imatinib 400 mg/day for GIST, among 470 patients in a randomised clinical trial (from Verweij et al [6]).
| Adverse effect | Grades 1/2 | Grades 3/4 |
|
| ||
| Anaemia | 82 | 7 |
| Oedema | 69 | 3 |
| Fatigue | 62 | 6 |
| Pleuritic pain | 47 | 4 |
| Nausea | 46 | 2.5 |
| Diarrhea | 46 | 1.7 |
| Cramps | 37 | 1.3 |
| Granulocytopenia | 34 | 7 |
| Rash | 24 | 2.3 |
| Myalgia | 24 | 0.2 |
| Arthralgia | 13 | 0 |